FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...
Si Hui Tan, PhD Director, Pipeline and Site Head, Singapore, Cirrus Therapeutics Ying Kai Chan, PhD Chief Executive Officer ...
Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...
Add Yahoo as a preferred source to see more of our stories on Google. USC Roski Eye Institute researchers are launching a phase 2b trial of a stem cell retinal implant designed to replace damaged ...
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) used its quarterly conference call to highlight a longer cash runway following ...
Please provide your email address to receive an email when new articles are posted on . A study presented at Angiogenesis, Exudation, and Degeneration 2024 provided insights on how geographic atrophy ...
—Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results